COVID-19
Conditions
Interventions
Teprenone 50mg p.o. 3 times a day after each meal for 10 days
Sponsors
ICHIHARA Eiki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 20 years-old or older 2. Confirmed diagnosis of COVID-19 with PCR or antigen test 3. temperature >= 37.5 degree Celsius 4. All subjects are required to have signed an informed consent document indicating that they understood the purpose of and procedures required for the study and are willing to participate in the study
Exclusion criteria
Exclusion criteria: 1. Teprenon use within 2 weeks of study treatment 2. Patient who needs ventilator or ECMO 3. Active infectious disease requiring systemic treatment except for stable NTM 4. During pregnancy, within 28 days of postparturition, or during lactation. 5. Unidentified patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intubation rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mortality 2. Period until fever relief 3. Oxygen dose 4. Change in chest CT images 5. Blood test values and theire rate of change 6. Severity 7. Period until discharge or lifting quarantine restrictions 8. Period until symptom disappearance 9. Adverse events | — |
Contacts
Public ContactEiki ICHIHARA
Okayama University Hospital
Outcome results
None listed